Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction
This study has been completed.
Study NCT00147654   Information provided by Pfizer
First Received: September 2, 2005   Last Updated: January 12, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Urinary Incontinence
Additional conditions recognized in this trial
Urinary Bladder Neck Obstruction
More general conditions related to this trial
Signs and Symptoms
Urethral Diseases
Urethral Obstruction
Urinary Bladder Diseases
Urination Disorders
Urologic Diseases
Urological Manifestations
Interventions listed in this trial
Tolterodine ER 4 mg QD
Tamsulosin 0.4 mg QD
Additional drug interventions recognized in this trial
Tamsulosin
Tolterodine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic alpha-Antagonists
Adrenergic Antagonists
Antineoplastic Agents
Cholinergic Agents
Cholinergic Antagonists
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services